Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-04

Clinical Trial Update: A Study of FF-10850 Topotecan Liposome Injection in Advanced Solid Tumors Including Merkel Cell Carcinoma [Phase 1]

View source ↗

Summary

This is a Phase 1 trial update for FF-10850 liposome-encapsulated topotecan in advanced solid tumors, including Merkel cell carcinoma; the study is currently ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FF-10850 Topotecan Liposome Injection (liposomal topotecan)

Snippet

Sponsor: Fujifilm Pharmaceuticals U.S.A., Inc. | Conditions: Advanced Solid Tumors, Merkel Cell Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING